Results 141 to 142 of about 696 (142)

Sustained unresponsiveness following long term Epicutaneous Immunotherapy (EPIT) with VIASKIN® peanut: Results of the OLFUS-VIPES PHASE IIb Study

, 2018
Terri Brown‐Whitehorn
openalex   +2 more sources

Phenotypic Analysis of Peanut-Responsive T Cells at Baseline in Subjects Enrolled in CoFAR6, a Randomized Placebo-Controlled Epicutaneous Immunotherapy (EPIT) Trial for the Treatment of Peanut Allergy

Journal of Allergy and Clinical Immunology, 2015
David Chiang, A. Wesley Burks, Wendy F. Davidson, Peter Dawson, Alexander Grishin, Alice K. Henning, Stacie M. Jones, Donald Y.M. Leung, Robert Lindblad, Andrew H. Liu, Amy M. Scurlock, Scott H. Sicherer, Brian P. Vickery, Robert A. Wood, Hugh A. Sampson, M. Cecilia Berin   +15 more
openalex   +2 more sources